Recombinant Rod Domain of Vimentin Reduces SARS-CoV-2 Viral Replication by Blocking Spike Protein–ACE2 Interactions
Although the SARS-CoV-2 vaccination is the primary preventive intervention, there are still few antiviral therapies available, with current drugs decreasing viral replication once the virus is intracellular. Adding novel drugs to target additional points in the viral life cycle is paramount in preve...
Main Authors: | Fong Wilson Lam, Cameron August Brown, Shannon Elizabeth Ronca |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/5/2477 |
Similar Items
-
Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections
by: Irene Ramos, et al.
Published: (2020-06-01) -
Detection of Anti-Vimentin Antibodies in Patients with Sarcoidosis
by: Anna Starshinova, et al.
Published: (2022-08-01) -
Biomarker Potential of Vimentin in Oral Cancers
by: Saie Mogre, et al.
Published: (2022-01-01) -
A fusion protein of vimentin with Fc fragment inhibits Japanese encephalitis virus replication
by: Taoping Zhang, et al.
Published: (2024-03-01) -
Dexamethasone impact on vimentin in human lens epithelial cells
by: Su Sheng, et al.
Published: (2016-01-01)